ライフサイエンスコーパス: cardioactive

1 ic agents, growth factors, gene vectors, and cardioactive and vasoactive agents to the heart.

2 al success, shifting the focus to innovative cardioactive biologicals and cell mimetic therapies, par

3 tematically identify previously unidentified cardioactive biologicals in an unbiased manner in vivo,

4 hypoxia and reoxygenation on the release of cardioactive factors by endothelial cells.

5 rs, demonstrating the potential of using the cardioactive glycoside oleandrin as a coadjuvant drug to

6 ired for abdominal inflation, which could be cardioactive in nature.

7 disease, diabetes mellitus, and those taking cardioactive medications were excluded.

8 g for age, sex, cardiac output, administered cardioactive medications, and underlying clinical condit

9 m had similar symptoms, comorbid conditions, cardioactive medications, pulmonary pressure, left atria

10 classical GLP-1R, or through GLP-1(9-36), a cardioactive metabolite generated by DPP-4-mediated clea

11 Previous findings suggest that crustacean cardioactive peptide (CCAP) activates the ecdysis motor

12 is circuit-specific by examining crustacean cardioactive peptide (CCAP) and bursicon circuits, which

13 including Eclosion hormone (EH), Crustacean cardioactive peptide (CCAP) and Bursicon.

14 Crustacean cardioactive peptide (CCAP) and related peptides are mul

15 integrated action of the hormone crustacean cardioactive peptide (CCAP) and the gastropyloric recept

16 ysis-triggering hormone (ETH) and crustacean cardioactive peptide (CCAP) elicit the first two motor b

17 Crustacean cardioactive peptide (CCAP) elicited expression of the m

18 ysis-triggering hormone (ETH) and crustacean cardioactive peptide (CCAP) evolved in the bilaterian la

19 Drosophila neurons that expresses crustacean cardioactive peptide (CCAP) has been shown previously to

20 of the crab, Cancer borealis, by crustacean cardioactive peptide (CCAP) is described.

21 Crustacean cardioactive peptide (CCAP) neurons and the peptide horm

22 g insulin producing cells (IPCs), crustacean cardioactive peptide (CCAP) neurons, and CCHamide-2 rece

23 noids may disrupt the function of crustacean cardioactive peptide (CCAP) neurons, either by directly

24 distinct from that of peripheral crustacean cardioactive peptide (CCAP) neurons, which potentiate th

25 ting the release of peptides from crustacean cardioactive peptide (CCAP) neurons.

26 postulated that the neuropeptide Crustacean cardioactive peptide (CCAP) plays a key role in the init

27 with high sequence similarity to crustacean cardioactive peptide (CCAP) receptors in insects and mam

28 Cancer borealis Proctolin (PROC), crustacean cardioactive peptide (CCAP), and red pigment concentrati

29 e peptides include allatostatins, crustacean cardioactive peptide (CCAP), calcitonin-like diuretic ho

30 pressin receptor group respond to crustacean cardioactive peptide (CCAP), corazonin, or adipokinetic

31 anism by which a peptide hormone, crustacean cardioactive peptide (CCAP), modulates the biphasic (pro

32 MRFamides, eclosion hormone (EH), crustacean cardioactive peptide (CCAP), myoinhibitory peptides (MIP

33 is tachykinin-related peptide Ia, crustacean cardioactive peptide (CCAP), red pigment-concentrating h

34 water uptake during moulting; and crustacean cardioactive peptide (CCAP), which is involved in stereo

35 We discovered that 2 crustacean cardioactive peptide (CCAP)-expressing neurons in Drosop

36 Crustacean cardioactive peptide (CCAP)-expressing neurons undergo p

37 he gene encoding the neuropeptide crustacean cardioactive peptide (CCAP).

38 hat bursicon is co-expressed with crustacean cardioactive peptide (CCAP).

39 (ETH), eclosion hormone (EH), and crustacean cardioactive peptide (CCAP).

40 , and all were immunopositive for crustacean cardioactive peptide (CCAP).

41 pansion defects when crossed to a crustacean cardioactive peptide (CCAP)/bursicon neuron-specific Gal

42 ted peptide, cholecystokinin, and crustacean cardioactive peptide are present in the POs by approxima

43 excitability by an analog of cAMP and small cardioactive peptide B (SCPB), the degree of attenuation

44 For example, the l-form of small cardioactive peptide B was detected at high levels in th

45 t detected; however, the DAACP form of small cardioactive peptide B was found in the neuropil of seve

46 fied a D-amino acid-containing form of small cardioactive peptide B, FMRFamide, and another D-amino a

47 ling of burs and pburs as well as crustacean cardioactive peptide in neurons of the ventral nervous s

48 PNS, MasITPL is coexpressed with crustacean cardioactive peptide in type II link nerve neurons (L1)

49 but a neurohemal system for the release of a cardioactive peptide is associated with the larval alary

50 P-related peptide (conoCAP-a, for cone snail CardioActive Peptide) and cloned the cDNA of its precurs

51 dergic neurons that produce CCAP (crustacean cardioactive peptide), which are key targets of ETH and

52 it is induced by an unrelated peptide (small cardioactive peptide), which exerts PKC-mediated effects

53 nt-dispersing hormone (beta-PDH), crustacean cardioactive peptide, and red pigment-concentrating horm

54 These neurons are immunoreactive to a cardioactive peptide, and this peptide probably modulate

55 n-related peptide Ia (CabTRP Ia), crustacean cardioactive peptide, red pigment-concentrating hormone,

56 peptides F, extended FMRFamides], crustacean cardioactive peptide, tachykinin-related peptides).

57 In addition, crustacean cardioactive peptide-immunoreactive fibers originating f

58 cretory neurons that also express crustacean cardioactive peptide.

59 e members of two peptide families, the small cardioactive peptides (SCPs) and the buccalins (BUCs), t

60 s putative peptide cotransmitters, the small cardioactive peptides (SCPs) and the buccalins (BUCs).

61 ss the neuropeptides FMRFamide and the small cardioactive peptides (SCPs), respectively.

62 This system is immunoreactive to cardioactive peptides and may function, therefore, in ho

63 P-1(9-36), and changes in levels of numerous cardioactive peptides.

64 inoid family, and the total synthesis of the cardioactive terpenoid (+)-cassaine, a nonsteroidal inhi